GlassScriptPhysician profile
Marcus Ali Thorne
NPI 1265466791
$8,595.08
in general payments reported to CMS, 2019-2025
17 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,437 · 2020: $2,167 · 2021: $93.80 · 2022: $1,531 · 2023: $91.96 · 2024: $54.91 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,454.00 | 2019-2020 | |
| Alpha Orthopedic Systems | $1,845.21 | 2019-2020 | |
| Crossroads Orthopedics, LLC | $1,446.33 | 2022-2024 | |
| Pacira Therapeutics, INC. | $134.30 | 2019 | |
| Bioventus LLC | $116.77 | 2021-2025 | Exogen Ultrasound Bone Healing System, Durolane, Durolane |
| Catalyst Orthoscience | $103.57 | 2025 | |
| Heraeus Medical, LLC. | $100.02 | 2021-2024 | Palacos |
| Wright Medical Technology, INC. | $92.30 | 2019 | |
| Stryker Corporation | $68.19 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $60.29 | 2019-2020 | |
| Depuy Synthes Sales INC. | $51.67 | 2021-2025 | Monovisc |
| Solventum Corporation | $39.22 | 2024-2025 | Prevena |
| Vertex Pharmaceuticals Incorporated | $18.81 | 2025 | |
| Orthofix Medical, INC. | $18.37 | 2025 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $17.33 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $15.80 | 2023 | Accrufer |
| Baudax Bio INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Thorne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.